Infraredx, Inc is acquired by Nipro Corporation and with it the TVC Imaging System

Nipro Corporation announced it has signed a definitive agreement to acquire Infraredx, Inc., an intravascular imaging company committed to advancing the diagnosis and management of coronary artery disease globally and manufacturer of the TVC Imaging System. Nipro Corporation offers products and technologies that meet the needs of patients and medical professionals in a wide range of fields, such as artificial organs, circulatory devices, test/diagnostic agents, injection/infusion solutions, ethical pharmaceuticals, and medical glass products. The agreement combines the strengths of Nipro Corporation and Infraredx, by leveraging Nipro's strong global cardiovascular portfolio and resources along with Infraredx's industry expertise in near infrared spectroscopy (NIRS) and intravascular ultrasound. The agreement will help introduce Nipro's cardiovascular product line into the United States, and continue Infraredx's mission to empower interventional cardiologists with the advanced imaging tools required to predict heart attacks and prevent them�catalyzing a global shift from reactive treatment to proactive care of coronary artery disease.